Amitkumar. R. Dhankani

A Brief Overview of Imeglimin Hydrochloride

Imeglimin hydrochloride is the first oral antidiabetic agent from the new glimin class that was first approved in Japan in 2021 and subsequently introduced in India in 2022. It is a derivative of tetrahydrotriazine made from metformin and tetrahydrotriazine precursors and primari...

A Brief Overview of Imeglimin Hydrochloride

Imeglimin hydrochloride is the first oral antidiabetic agent from the new glimin class that was first approved in Japan in 2021 and subsequently introduced in India in 2022. It is a derivative of tetrahydrotriazine made from metformin and tetrahydrotriazine precursors and primari...